問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of General Internal Medicine

Digestive System Department

Division of Hematology & Oncology

MacKay Memorial Hospital (在職)

Division of Thoracic Medicine

Division of Hematology & Oncology

MacKay Memorial Hospital

Division of Hematology & Oncology

更新時間:2023-09-19

蘇建維Su, Chien-Wei
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 10 個月

篩選

List

39Cases

2025-12-01 - 2032-08-02

Others

Not yet recruiting
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
  • Condition/Disease

    Primary Biliary Cholangitis

  • Test Drug

    Capsules

Participate Sites
7Sites

Not yet recruiting7Sites

2015-04-01 - 2020-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
20Sites

Terminated19Sites

2021-01-04 - 2025-12-31

Others

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting5Sites

Terminated1Sites

2020-07-01 - 2024-12-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting3Sites

Terminated2Sites

2017-09-01 - 2019-01-03

Others

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Terminated7Sites

2020-11-06 - 2023-12-26

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Not yet recruiting2Sites

Recruiting5Sites

2018-11-30 - 2025-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Not yet recruiting1Sites

Recruiting8Sites

林錫銘
Linkou Chang Gung Medical Foundation

Digestive System Department

2023-10-31 - 2027-08-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Not yet recruiting7Sites

Recruiting1Sites

2023-11-15 - 2031-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Not yet recruiting9Sites

Recruiting2Sites

2018-11-01 - 2025-01-13

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

1 2 3 4